Gain or amplification of the CDK9 gene is common in prostate cancer, particularly in CRPC (Fig. 1d), and copy number alterations explain, at least in part, increased CDK9 mRNA expression (Fig. 1e). This evidence concerns the gene CDK9 and Familial prostate cancer.